Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

What role will CAR-Tregs play in the growing advanced therapy landscape?

To see true progress, pharma manufacturers will have to do away with their legacy systems.

Where are pharma companies falling behind when it comes to the environment?

How can smart packaging designs help boost medical adherance?

How will pharma protect itself from cyberthreats as it continues to adopt AI systems?

An inside view on the San Diego company working to bring drug delivering contact lenses to market.

Biosimilars have been available in Europe for years. Is the US still lagging behind?